Ghostwriting, which is prominent in the psychiatry literature, is a scam in which pharmaceutical companies use an academic sleight of hand to stump the naïve reader. It is time for editors of the major medical journals to use the same standards of authorship found in the humanities and social sciences.
A new study associates the presence of meaning in life with well-being and cognitive functioning in an adult population.
A new study, published in the JAMA Psychiatry, investigates the effect of stimulant ‘ADHD’ drugs on the brains of children and young adults. The...
Jeffrey LIeberman and colleagues have published a paper in the American Journal of Psychiatry stating that there is no evidence that psychiatric drugs cause long-term harm, and that the evidence shows that these drugs provide a great benefit to patients. A close examination of their review reveals that it is a classic example of institutional corruption, which was meant to protect guild interests.
Peer-Support Groups Were Right, Guidelines Were Wrong: Dr. Mark Horowitz on Tapering Off Antidepressants
In an interview with MIA, Dr. Horowitz discusses his recent article on why tapering off antidepressants can take months or even years.
Results from a 30-year prospective study demonstrated worse outcomes for people who took antidepressants, even after controlling for gender, education level, marriage, baseline severity, other affective disorders, suicidality, and family history of depression.
A new study suggests that taking antidepressants impairs empathy, while the experience of depression itself does not.
Hundreds of people have been given remote control deep brain stimulation implants for psychiatric disorders such as depression, OCD and Tourette’s. Yet DBS specialists still have no clue about its mechanisms of action and research suggests its hefty health and safety risks far outweigh benefits.
Researcher criticizes the many ways opposing viewpoints and dissenting voices are squashed in the field of medicine.
Mixed-Methods study explores the experiences of antipsychotic discontinuation among service users.
Researchers suggest that the pharmaceutical industry had a vested interest in using the term “discontinuation” in order to hide the severity of physical dependence and withdrawal reactions many people experience from antidepressants.
Psychiatrist Mohammed Abouelleil Rashed explores a way forward for psychiatry in responding to the Mad activism of service users.
Sir Robin Murray, a professor at the Institute of Psychiatry, Psychology, and Neuroscience in London, states that he ignored social factors that contribute to ‘schizophrenia’ for too long. He also reports that he neglected the negative effects antipsychotic medication has on the brain.
A new study, published in Psychotherapy Research, explores how having a career in psychotherapy affects therapists’ personal lives.
Long-term benzodiazepine use shown to effect cognitive function during current use and for years after drug discontinuation.
MIA's Zenobia Morrill interviews Lucy Johnstone about the reaction to the Power Threat Meaning Framework, her life influences, and her hopes for the future.
A new study finds that clinicians’ disregard for mental health patients’ insight into their own condition may be detrimental to treatment.
A new review, published in BMJ Evidence-Based Medicine, concludes that antidepressants should not be used as the risks outweigh evidence for benefits.
Effects of discontinuing SSRIs and SNRIs reported on an online forum indicate significant and long-lasting withdrawal symptoms.
In a new report, the United Nations Special Rapporteur on the right to health, Dr. Dainius Pūras, calls for a move away from the biomedical model and “excessive use of psychotropic medicines.”
A new study explores how mindfulness impacts self-compassion and meaning in life to increase mental health and wellbeing.
MIA’s Gavin Crowell-Williamson interviews psychologist Rosie Phillips Davis about her presidential initiative to address deep poverty.
When Carina Håkansson sent out an invitation for a symposium on "Pharmaceuticals: Risks and Alternatives," some of the world's top scientists, along with experts-by-experience, came from 13 countries to explore better ways to respond to people in crisis.
In 1972, prisoners at Holmesburg Prison in Philadelphia were paid $3 to have their eyes held open with clamps and hooks while Johnson & Johnson's baby shampoo was dropped into them. In 2011, mothers of newborns were arrested when their babies tested positive for exposure to cannabis, a false result caused by the use of Johnson & Johnson’s Head-to-Toe Foaming Baby Wash. Young men have undergone mastectomies to remove breasts grown as a result of Johnson & Johnson antipsychotics, which were used as a result of Johnson & Johnson's criminal promotion of its drugs for off-label purposes. And now, Johnson & Johnson has announced the removal of carcinogenic chemicals from their No More Tears baby shampoo.
A large study of the population in Taiwan reveals that long-term use of benzodiazepine drugs, commonly prescribed for anxiety, significantly increases the risk for brain, colorectal, and lung cancers. The research, published open-access in the journal Medicine, also identifies the types of benzodiazepines that carry the greatest cancer risk.